Rajesh Devraj
Consultant / Advisor at DECIPHERA PHARMACEUTICALS, INC.
Network origin in Rajesh Devraj first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
Atlas Venture Advisors, Inc.
 Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors Inc (Atlas Venture Advisors) is a venture capital firm founded in 1980 by Christopher Julian Spray. The firm is headquartered in Cambridge, Massachusetts.
86
| Private Company | Investment Managers | 86 |
| Subsidiary | Biotechnology | 28 | |
Disarm Therapeutics, Inc.
 Disarm Therapeutics, Inc. BiotechnologyHealth Technology Disarm Therapeutics, Inc. engages in the development of therapeutics to treat patients with neurological diseases. It includes multiple sclerosis, amyotrophic lateral sclerosis, glaucoma, and peripheral neuropathies. The company was founded by Jason Rhodes, Jeffrey Milbrandt, Raul Krauss, Aaron DiAntonio, and Rajesh Devraj on October 21, 2016 and is headquartered in Cambridge, MA.
15
| Subsidiary | Biotechnology | 15 |
Rectify Pharmaceuticals LLC
 Rectify Pharmaceuticals LLC Miscellaneous Commercial ServicesCommercial Services Rectify Pharmaceuticals LLC is a biotech company that is developing positive functional modulators (PFMs) to address the underlying cause of serious ABC transporter-mediated diseases. The company is based in Cambridge, MA and was founded by Jonathan Moore. The company's team includes Xiaobing Li as Chief Development Officer, Robert Hughes as Executive Vice President of Drug Discovery and Preclinical Development, and Leif-Ann Tuohey as Senior Vice President and Head of Business Development. The company has received $100 million in Series A financing from Atlas Venture, Omega Funds, Forbion, and Longwood Fund. The CEO is Rajesh Devraj, who is also a venture partner at Atlas Venture.
8
| Holding Company | Miscellaneous Commercial Services | 8 |
Euclises Pharmaceuticals, Inc.
 Euclises Pharmaceuticals, Inc. Hospital/Nursing ManagementHealth Services Euclises Pharmaceuticals, Inc. operates as a biopharmaceutical company. The firm develops a portfolio of COX-2 inhibitors optimized for cancer treatment based on its proprietary Euclicoxib platform and is in the process of selecting a lead clinical development candidate. The company was founded by John J. Talley in 2011 and is headquartered in St. Louis, MO.
5
| Holding Company | Hospital/Nursing Management | 5 |
Indalo Therapeutics, Inc.
 Indalo Therapeutics, Inc. BiotechnologyHealth Technology Indalo Therapeutics, Inc. operates as a biopharmaceutical firm that develops integrin antagonists for patients suffering from serious fibrotic diseases such as nonalcoholic steatohepatitis (NASH) and idiopathic pulmonary fibrosis (IPF). The company was founded by David Griggs, Williamson Z. Bradford III, Peter Ruminski, and Robert W. Karr and is headquartered in Cambridge, MA.
2
| Holding Company | Biotechnology | 2 |
Padlock Therapeutics, Inc.
 Padlock Therapeutics, Inc. BiotechnologyHealth Technology Padlock Therapeutics, Inc. develops medicines targeting protein-arginine deiminases. It develops drugs that block the protein-arginine deiminase (PAD) enzymes. The firm leverages the breakthrough science on the role of protein citrullination in disease to develop drugs targeting protein-arginine deiminase (PAD) enzymes. The company was founded by Paul Thompson, Kerri Mowen, Todd A. Huffman and Michael Gilman in January 2014 and is headquartered in Cambridge, MA.
1
| Subsidiary | Biotechnology | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Rajesh Devraj via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
Deciphera Pharmaceuticals LLC
 Deciphera Pharmaceuticals LLC BiotechnologyHealth Technology Deciphera Pharmaceuticals LLC discovers and develops pharmaceutical preparations. It designs kinase inhibitor therapies that target the hallmarks of cancer biology. The firm’s clinical pipeline of kinase inhibitors includes tumor-targeted therapies and immuno-targeted therapies. It offers DCC-2618, Rebastinib, and DCC-3014. The company was founded by Daniel L. Flynn in 2003 and is headquartered in Waltham, MA. | Biotechnology | Director/Board Member Director of Finance/CFO Director/Board Member Chairman Chief Executive Officer Founder Director/Board Member Chief Executive Officer Director/Board Member Director/Board Member | |
Atlas Venture Life Science Advisors LLC
 Atlas Venture Life Science Advisors LLC Investment ManagersFinance Atlas Venture Life Science Advisors LLC (Atlas Venture) is a venture capital firm founded in 2014. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Private Equity Investor Private Equity Investor Private Equity Investor Private Equity Investor Private Equity Investor Consultant / Advisor Consultant / Advisor Private Equity Investor Consultant / Advisor | |
Nimbus Therapeutics LLC
 Nimbus Therapeutics LLC BiotechnologyHealth Technology Nimbus Therapeutics LLC provides drug discovery research services. It is a computational technology-driven paradigm to rapidly advance a diverse pipeline of novel small molecule product candidates into clinical development. The company was founded by Bruce Lee Booth in 2009 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member Director/Board Member Founder Director/Board Member Corporate Officer/Principal Consultant / Advisor Chief Operating Officer Chief Executive Officer Chief Executive Officer | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal Chief Operating Officer Director/Board Member | |
| Harvard Medical School | College/University | Doctorate Degree Corporate Officer/Principal Doctorate Degree Graduate Degree Corporate Officer/Principal Corporate Officer/Principal Graduate Degree | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Doctorate Degree Undergraduate Degree Doctorate Degree Doctorate Degree Doctorate Degree Doctorate Degree | |
| BIOGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member Chief Tech/Sci/R&D Officer Director/Board Member Corporate Officer/Principal Private Equity Investor | |
| KYMERA THERAPEUTICS, INC. | Biotechnology | Director/Board Member Founder Director/Board Member Director/Board Member Director/Board Member Private Equity Investor | |
| GENERATION BIO CO. | Pharmaceuticals: Major | Founder Chief Executive Officer Chief Tech/Sci/R&D Officer Director/Board Member Director/Board Member Chief Tech/Sci/R&D Officer | |
| Stanford University | College/University | Undergraduate Degree Graduate Degree Masters Business Admin Undergraduate Degree Graduate Degree | |
HotSpot Therapeutics, Inc.
 HotSpot Therapeutics, Inc. BiotechnologyHealth Technology HotSpot Therapeutics, Inc. develops new allosteric therapies with the ability to treat disease. The company was founded by Jonathan Montagu and Geraldine Harriman and is headquartered in Boston, MA. | Biotechnology | Chairman Consultant / Advisor Founder Director/Board Member Corporate Officer/Principal | |
| THIRD HARMONIC BIO, INC. | Pharmaceuticals: Major | Director/Board Member Chairman Director/Board Member Director/Board Member Director/Board Member | |
Q32 Bio, Inc.
 Q32 Bio, Inc. BiotechnologyHealth Technology Q32 Bio Operations, Inc. develops immunomodulatory therapies with protein based molecules using a platform. The company was founded by Shelia Violette and is headquartered in Cambridge, MA. | Biotechnology | Founder Chairman Chief Executive Officer Founder Consultant / Advisor | |
Nimbus Apollo, Inc.
 Nimbus Apollo, Inc. Pharmaceuticals: MajorHealth Technology Nimbus Apollo, Inc. provides drug discovery research services. The company is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member Chairman Director/Board Member Chief Executive Officer | |
Cadent Therapeutics, Inc.
 Cadent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cadent Therapeutics, Inc. develops novel small molecule therapeutics to treat schizophrenia and other cognitive disorders. It focuses on modulating synaptic plasticity, the mechanism through which the brain builds and evolves the synaptic networks that carry out cognitive functions such as learning and memory. The company was founded by Kollol Pal, Frank S. Menniti, and Bertrand Leo Chenard in 2010 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Chairman Founder Director/Board Member Chief Executive Officer | |
| VIGIL NEUROSCIENCE, INC. | Biotechnology | Chief Executive Officer Chairman Private Equity Investor Director/Board Member | |
| MONSANTO | Wholesale Distributors | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| Princeton University | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Doctorate Degree | |
| REPLIMUNE GROUP, INC. | Biotechnology | Director/Board Member Director/Board Member Investor Relations Contact Director/Board Member | |
| SPERO THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director/Board Member Founder Chief Operating Officer | |
Matchpoint Therapeutics, Inc.
 Matchpoint Therapeutics, Inc. BiotechnologyHealth Technology Matchpoint Therapeutics, Inc. is a biotechnology company based in Cambridge, MA. The company aims to discover and develop precision covalent medicines to transform the treatment of immune diseases and other serious illnesses. Matchpoint's proprietary Advanced Covalent Exploration (ACE) platform integrates advanced chemoproteomics, machine learning, and covalent chemistry library evolution. The company was founded by Jianwei Che, Edward Chouchani, Tinghu Zhang, Nathanael S. Gray, and the CEO is G. Andre Turenne. | Biotechnology | Chairman Director/Board Member Director/Board Member Chief Executive Officer | |
| SURFACE ONCOLOGY, INC. | Biotechnology | Chief Executive Officer Chief Tech/Sci/R&D Officer Director/Board Member Chief Operating Officer | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Sales & Marketing Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
K36 Therapeutics, Inc.
 K36 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology K36 Therapeutics, Inc. develops small molecule therapeutics. The company is based in Cambridge, MA. The company was founded in 2021. The CEO is Terry Connolly. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Chief Executive Officer | |
Scorpion Therapeutics, Inc.
 Scorpion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Scorpion Therapeutics, Inc. provides health care services. The company is headquartered in Boston, MA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| University of Pennsylvania | College/University | Doctorate Degree Doctorate Degree Doctorate Degree | |
| Yale University | College/University | Undergraduate Degree Undergraduate Degree Doctorate Degree | |
Arteaus Therapeutics LLC
 Arteaus Therapeutics LLC BiotechnologyHealth Technology Arteaus Therapeutics LLC develops therapies for migraine prevention. The company was founded by Dave Grayzel and Scott C. Chappel on July 15, 2011 and is headquartered in Cambridge, MA. | Biotechnology | Founder Chief Executive Officer Founder | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal President Corporate Officer/Principal | |
| Dartmouth College | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
Novartis Institutes for Biomedical Research, Inc.
 Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| BICYCLE THERAPEUTICS PLC | Biotechnology | Director/Board Member Director/Board Member Chief Tech/Sci/R&D Officer | |
Navitor Pharmaceuticals, Inc.
 Navitor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Navitor Pharmaceuticals, Inc. develops medicine for age-related diseases. Its drug discovery platform targets mTORC1, which responds to and integrates the cell’s response to nutrient availability and plays a key role in protein synthesis and cellular growth. The company was founded by Alan L. Crane, David Sabatini and David Goldfarb and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Chief Executive Officer | |
Accent Therapeutics, Inc.
 Accent Therapeutics, Inc. BiotechnologyHealth Technology Accent Therapeutics, Inc. operates as a biopharmaceutical company which develops treatments for cancer patients. The company was founded by Howard Y. Chang, Chuan He and Robert A. Copeland in September 2017 and is headquartered in Lexington, MA. | Biotechnology | Director/Board Member Director/Board Member Founder | |
| ACCELERON PHARMA INC. | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Third Rock Ventures LLC
 Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures LLC (Third Rock Ventures) is a venture capital firm founded in 2007 by Mark Levin, Robert Tepper, Kevin Starr and Nick Leschly. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Private Equity Investor Private Equity Analyst Private Equity Investor | |
| IKENA ONCOLOGY, INC. | Biotechnology | Director/Board Member Director/Board Member Founder | |
Korro Bio, Inc.
 Korro Bio, Inc. BiotechnologyHealth Technology Korro Bio, Inc. engages in the development of a bio therapeutics. It focuses on a proprietary platform designed to selectively edit messenger RNA and recode specific codons to effect changes in protein structure and function across multiple tissues. The company was founded by Jean-Fran?ois Formela, Josh Rosenthal, Nessan Bermingham, and Andrew Fraley in 2018 and is headquartered in Cambridge, MA. | Biotechnology | Founder Private Equity Investor Chief Executive Officer | |
| Kellogg School of Management | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
| DYNE THERAPEUTICS, INC. | Biotechnology | Founder Chief Executive Officer Chief Tech/Sci/R&D Officer | |
| University of California, Berkeley | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| TRANSLATE BIO, INC. | Biotechnology | Founder Director/Board Member Director/Board Member |
Statistics
International
| United States | 49 |
| United Kingdom | 3 |
Sectoral
| Health Technology | 36 |
| Consumer Services | 11 |
| Finance | 3 |
| Distribution Services | 2 |
| Commercial Services | 2 |
Operational
| Director/Board Member | 522 |
| Corporate Officer/Principal | 262 |
| Independent Dir/Board Member | 129 |
| Chief Executive Officer | 113 |
| Undergraduate Degree | 88 |
Most connected contacts
| Insiders | |
|---|---|
| Jean-Francois Formela | 48 |
| Bruce Booth | 40 |
| Christopher Lynch | 38 |
| John Maraganore | 38 |
| Peter Barrett | 38 |
| Ryan Moore | 38 |
| Otello Stampacchia | 37 |
| Jean George | 33 |
| Bobby Sandage | 29 |
| Mark Iwicki | 26 |
| David Steinberg | 24 |
| Jason Rhodes | 24 |
| Ankit Mahadevia | 23 |
| Michael Gladstone | 23 |
| Dave Grayzel | 23 |
- Stock Market
- Insiders
- Rajesh Devraj
- Company connections
